Gilrose Pharmaceuticals, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Gilrose Pharmaceuticals, LLC
Quantité totale PI 17
Rang # Quantité totale PI 90 249
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 960 904

Brevets

Marques

14 0
1 0
2 0
0
 
Dernier brevet 2021 - Pre-frontal cortex processing di...
Premier brevet 2012 - Method of treating apraxia of sp...

Derniers inventions, produits et services

2020 Invention Pre-frontal cortex processing disorder speech, gait and limb impairments treatment. A methylpheni...
2019 Invention Pre-frontal cortex processing disorder speech gait and limb impairments treatment. A methylphenid...
2016 Invention Pre-frontal cortex processing disorder, gait and limb impairment treatment. A methylphenidate, pa...
Invention Pre-frontal cortex processing disorder gait and limb impairments treatment. A methylphenidate, pa...
2015 Invention Treatment for cerebral palsy gait impairment. A methylphenidate, particularly including dextro-th...
Invention Pharmaceutical intervention for treating an apraxia of speech in children. A pharmaceutical inter...
Invention Pharmaceutical intervention and method for treating an apraxia of speech in children. A pharmaceu...
2014 Invention Treatment of cerebral palsy impaired speech in children. Cerebral palsy impaired speech in childr...
Invention Treatment for cerebral palsy impaired speech in children. Cerebral palsy impaired speech in chil...
2013 Invention Treatment for cerebral palsy impaired speech in children. Cerebral palsy impaired speech in child...
2012 Invention Method of treating apraxia of speech in children. A therapeutic method for treating apraxia of sp...